Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R LANDAU

Showing results (321-330 of 335) with videos related to

Pageof 34
Sort By:
Nature Immunology|February 14, 2012
SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphatesHichem Lahouassa, Waaqo Daddacha, Henning Hofmann, et al.
Nature Medicine|November 1, 1996
The role of a mutant CCR5 allele in HIV-1 transmission and disease progressionY Huang, W A Paxton, S M Wolinsky, et al.
Cell Death and Differentiation|December 4, 2021
The NSP14/NSP10 RNA repair complex as a Pan-coronavirus therapeutic targetGergely Rona, Andras Zeke, Bearach Miwatani-Minter, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 22, 2023
Removal of innate immune barriers allows efficient transduction of quiescent human hematopoietic stem cellsErika Valeri, Giulia Unali, Francesco Piras, et al.
Nature Medicine|September 14, 2012
SAMHD1 restricts HIV-1 infection in resting CD4(+) T cellsHanna-Mari Baldauf, Xiaoyu Pan, Elina Erikson, et al.
Cell|November 15, 1996
CD4-independent infection by HIV-2 is mediated by fusin/CXCR4M J Endres, P R Clapham, M Marsh, et al.
Iscience|February 27, 2023
Delta-Omicron recombinant escapes therapeutic antibody neutralizationRalf Duerr, Hao Zhou, Takuya Tada, et al.
Biorxiv : the Preprint Server for Biology|December 19, 2025
Virus-like particles enable targeted gene engineering and pooled CRISPR screening in primary human myeloid cellsHyuncheol Jung, Pascal Devant, Carter Ching, et al.
Biorxiv : the Preprint Server for Biology|April 12, 2022
Delta-Omicron recombinant escapes therapeutic antibody neutralizationRalf Duerr, Hao Zhou, Takuya Tada, et al.
Microbiology Spectrum|February 16, 2022
High-Titer Neutralizing Antibodies against the SARS-CoV-2 Delta Variant Induced by Alhydroxyquim-II-Adjuvanted Trimeric Spike AntigensClaudio Counoupas, Paco Pino, Alberto O Stella, et al.
Pageof 34

Showing results (321-330 of 335) with videos related to

Sort By:
Pageof 34
Nature Immunology|February 14, 2012
SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphatesHichem Lahouassa, Waaqo Daddacha, Henning Hofmann, et al.
Nature Medicine|November 1, 1996
The role of a mutant CCR5 allele in HIV-1 transmission and disease progressionY Huang, W A Paxton, S M Wolinsky, et al.
Cell Death and Differentiation|December 4, 2021
The NSP14/NSP10 RNA repair complex as a Pan-coronavirus therapeutic targetGergely Rona, Andras Zeke, Bearach Miwatani-Minter, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 22, 2023
Removal of innate immune barriers allows efficient transduction of quiescent human hematopoietic stem cellsErika Valeri, Giulia Unali, Francesco Piras, et al.
Nature Medicine|September 14, 2012
SAMHD1 restricts HIV-1 infection in resting CD4(+) T cellsHanna-Mari Baldauf, Xiaoyu Pan, Elina Erikson, et al.
Cell|November 15, 1996
CD4-independent infection by HIV-2 is mediated by fusin/CXCR4M J Endres, P R Clapham, M Marsh, et al.
Iscience|February 27, 2023
Delta-Omicron recombinant escapes therapeutic antibody neutralizationRalf Duerr, Hao Zhou, Takuya Tada, et al.
Biorxiv : the Preprint Server for Biology|December 19, 2025
Virus-like particles enable targeted gene engineering and pooled CRISPR screening in primary human myeloid cellsHyuncheol Jung, Pascal Devant, Carter Ching, et al.
Biorxiv : the Preprint Server for Biology|April 12, 2022
Delta-Omicron recombinant escapes therapeutic antibody neutralizationRalf Duerr, Hao Zhou, Takuya Tada, et al.
Microbiology Spectrum|February 16, 2022
High-Titer Neutralizing Antibodies against the SARS-CoV-2 Delta Variant Induced by Alhydroxyquim-II-Adjuvanted Trimeric Spike AntigensClaudio Counoupas, Paco Pino, Alberto O Stella, et al.
Pageof 34